Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
In our hospital, we ensure that patients are able to select the type of renal replacement therapy they receive. We also believe that patients who select hemodialysis can benefit from having their own choice of blood access after receiving sufficient information, and we have put this into practice, primarily supporting patients’ choice of access since 2018. In this study, we analyzed the changes that have occurred during this period, as well as analyzing those patients who opted for the use of tunneled hemodialysis catheters (TDCs).
1) We initially investigated choice of access in 166 patients (mean age 67.7 ± 9.8 years; 132 male, 34 female; 101 [60.8%] with diabetes) who started hemodialysis at our hospital’s Kidney Center during a 10-year period (2013–2022).
2) Since 2018, patients with no significant medical problems have been able to select their preferred blood access type (arteriovenous fistulas (AVF), arteriovenous grafts, and TDCs), and we investigated the resulting changes.
3) We also investigated the outcomes in patients who selected TDCs (we use Tesio® catheter) in the period 2018–2022.
1)The following hemodialysis access types were selected: AVF in 66 cases (39.8%), arteriovenous grafts in 13 cases (7.9%), and catheters in 87 cases (52.4%).
2)Among the 67 cases in 2018–2022, AVFs were used in 5 cases (7.5%), arteriovenous grafts in 2 cases (3.0%), and TDCs in 60 cases (89.6%). Thus, most patients selected TDCs.
3)Kaplan-Meir analysis of the 60 patients (mean age 69.4 ± 11.4 years; 50 male, 10 female; 33 with diabetes mellitus) who selected TDCs in 2018–2022 estimated survival rates of 95.8%, 76.4%, 69.2%, and 57.6% at 1, 2, 3, and 4 years, respectively. There were 11 deaths, caused by malignancy (3 cases), sudden death (2 cases), heart failure (2 cases), and one case each of intracerebral hemorrhage, pneumonia, urinary tract infection, and connective tissue disease. Catheter-related complications included three cases of pyogenic spondylitis (all in patients who started treatment in 2018), six of thrombolysis, four of infection (including tunnel infection), and four of replacement (owing to infections or thrombi). When offered their own choice of access, many patients selected catheters, with the main reason being to avoid AVF puncture pain.
Changing the primary decision-maker for the choice of access from the healthcare worker (mainly the doctor) to the patient led to a substantial increase in the number of patients selecting TDCs. This implies that the aversion to AVF punctures far exceeds the expectations of healthcare workers. Although some reports have stated that TDCs are safe, even compared with other types of permanent catheters, at our hospital, we observed no major differences in the survival rate or cause of death compared with AVF (see the official figures of the Japanese Society for Dialysis Therapy). Another benefit of patient-led selection after explaining the respective strengths and weaknesses of catheters and AVF is that it encourages patients to be actively involved in their subsequent treatment. As such, this can be considered a method for enabling shared decision-making in treatment.
